Marico Bets Big on Vietnam: Skinetiq Acquisition at Premium Valuation

CONSUMER-PRODUCTS
Whalesbook Logo
AuthorRiya Kapoor|Published at:
Marico Bets Big on Vietnam: Skinetiq Acquisition at Premium Valuation
Overview

Marico Limited has acquired a 75% stake in Vietnamese direct-to-consumer skincare company Skinetiq Joint Stock Company for approximately ₹350 crore. This move, intended to bolster Marico's premium beauty presence in Vietnam, values Skinetiq at a P/S multiple of roughly 2.3x its projected 2025 revenue of ₹152 crore. The acquisition leverages Skinetiq's digital-first 'Candid' brand and exclusive distribution for 'Murad' in a market where e-commerce drives half of all beauty sales.

The Valuation Gambit in Vietnam's Digital Beauty Boom

Marico Limited is significantly expanding its international footprint by acquiring a 75% controlling stake in Skinetiq Joint Stock Company, a Vietnamese direct-to-consumer skincare enterprise. The transaction, valued at an equity valuation of approximately ₹350 crore, translates to a Price-to-Sales (P/S) multiple of roughly 2.3 times Skinetiq's projected calendar year 2025 revenue of ₹152 crore. This premium valuation signals Marico's aggressive intent to capture market share within Vietnam's rapidly expanding beauty sector, which is increasingly dominated by digital channels. Skinetiq, established in 2020, operates primarily through online avenues, capitalizing on social commerce and dermatology-focused content to engage younger consumers with its 'Candid' brand and secure distribution for 'Murad'. The deal aligns with Marico's stated ambition to augment its international Direct-to-Consumer (D2C) capabilities and bolster its presence in premium beauty segments. Marico, a diversified Indian consumer goods giant with a market capitalization nearing ₹98,000 crore and a P/E ratio hovering around 57x, sees strategic imperative in Vietnam's growing economy, where e-commerce now accounts for approximately 50% of beauty product consumption.

Strategic Brand Consolidation and Market Penetration

The acquisition provides Marico with direct access to Skinetiq's digital-first skincare brand, 'Candid', known for its science-backed formulations targeting the mid-premium segment. Furthermore, Marico gains exclusive distribution rights for the luxury clinical skincare brand 'Murad' within Vietnam. Skinetiq has demonstrated substantial revenue growth, ascending from ₹45 crore in calendar year 2023 to ₹152 crore in calendar year 2025, while maintaining robust EBITDA margins in the mid-twenties. This performance underscores the potential within Vietnam's beauty and personal care market, projected to reach $2.74 billion by 2025 with continued growth. Marico's existing international operations already contribute about 25% to its total group revenue, which stood at ₹10,800 crore in FY 2024-25 [cite: News1]. The company's strategy involves scaling innovation and deepening consumer connections in Vietnam's competitive digital-first retail environment, leveraging its financial strength and operational expertise.

The Forensic Bear Case: Valuation Risks and D2C Dependencies

Despite the strategic rationale, the acquisition presents notable risks. The valuation of Skinetiq at ₹350 crore for approximately ₹152 crore in projected revenue implies a significant premium that could strain Marico's profitability if growth expectations are not met. The heavy reliance on e-commerce and social commerce channels, while a growth engine, also exposes Skinetiq to intense competition, evolving platform algorithms, and fluctuating digital marketing costs. Vietnam's beauty market, while expanding, is dynamic and increasingly crowded, with platforms like Shopee, Lazada, and TikTok Shop serving as battlegrounds for numerous brands. Furthermore, Marico's own track record shows instances where its stock price experienced minor dips following acquisition announcements. The company has also faced scrutiny for past slower sales growth. Integrating Skinetiq and effectively scaling its brands requires navigating Vietnam's specific market dynamics, consumer preferences, and regulatory nuances, posing inherent execution challenges. The company's reliance on two founders, who established Skinetiq only in 2020, also introduces potential long-term leadership continuity risks, especially as the business scales under Marico's stewardship.

Future Outlook and Strategic Integration

Marico's leadership, including MD and CEO Saugata Gupta, views this investment as a crucial step in its strategy to build a premium beauty presence in Vietnam and enhance its global D2C capabilities. The company's long-term vision includes achieving ₹20,000 crore in revenue by 2030, supported by purposeful brand building and innovation. This acquisition signifies Marico's confidence in Vietnam's macroeconomic fundamentals and its potential to introduce further brands into the market. Investors will monitor Marico's ability to successfully integrate Skinetiq, leverage its digital-first model, and drive sustainable, profitable growth in this emerging Southeast Asian market, balancing the premium valuation against the inherent risks of rapid expansion in a digitally-driven consumer landscape.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.